Related Experiment Videos
[CEA studies in endometrial cancer].
1Frauenklinik des Bezirkskrankenhauses, Wismar.
Zentralblatt Fur Gynakologie
|January 1, 1989
Summary
Elevated Carcinoembryonic antigen (CEA) levels were observed in 25% of endometrial cancer patients before treatment. Post-treatment monitoring of CEA in serum is crucial for patients with endometrial cancer.
Area of Science:
- Oncology
- Biochemistry
Context:
- Endometrial cancer diagnosis and treatment
- Radioimmunoassay (RIA) for biomarker detection
Purpose:
- To assess the utility of Carcinoembryonic antigen (CEA) as a biomarker in endometrial cancer.
- To evaluate pre- and post-treatment CEA levels in patients.
Summary:
- Serum CEA concentrations were measured in 63 female patients with endometrial cancer between 1983 and 1986.
- Pre-therapeutically, 25% of patients across all histopathological stages exhibited elevated CEA levels.
- Semilogarithmic plots illustrated CEA values during post-therapeutic follow-up, highlighting its role in monitoring.
Impact:
- CEA monitoring is primarily valuable for the post-therapeutic surveillance of operated and irradiated endometrial cancer patients.
- This study supports the use of CEA as a potential biomarker for endometrial cancer management.